NCT07239453已完成1 期
An Open-Label, Randomized, Single Oral Dose, Two-Sequence, Two-Period, CrossovSer Bioequivalence Study of "DA-2902" and "DA-2902-R" in Healthy Adults Under Fed Conditions
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- AUCt
研究概览
简要总结
This study is to compare pharmacokinetics and safety profiles of DA-2902 and DA-2902-R in healthy adult subjects
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 19 Years 至 44 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy volunteers
- •BMI between 18 and 30 kg/m2
- •Body weight: Male≥50kg, Female≥45kg
- •Subjects who have signed an informed consent themselves after receiving detailed explanation about clinical study
排除标准
- •Subjects with clinically significant medical history
- •Subjects with history of drug abuse or addicted
- •Subjects with allergy or drug hypersensitivity
研究组 & 干预措施
Sequence A
Experimental
干预措施: DA-2902 (Drug)
Sequence B
Experimental
干预措施: DA-2902 (Drug)
Sequence B
Experimental
干预措施: DA-2902-R (Drug)
Sequence A
Experimental
干预措施: DA-2902-R (Drug)
结局指标
主要结局
AUCt
时间窗: pre-dose ~ 72 hr of pose-dose
Cmax
时间窗: pre-dose ~ 72 hr of post-dose
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed StateNCT07046715Dong-A ST Co., Ltd.40
尚未招募
1 期
Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult SubjectsNCT06993181Dong-A ST Co., Ltd.48
已完成
1 期
Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male VolunteersHealthyNCT02557594Dong-A ST Co., Ltd.36
已完成
1 期
Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy VolunteersOsteoporosisNCT03824171Addpharma Inc.52
已完成
1 期
Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)HealthyNCT04938752Dong-A ST Co., Ltd.30